Health-related quality of life with enzalutamide versus flutamide in castration-resistant prostate cancer from the AFTERCAB study

BACKGROUND: Patient-reported outcome (PRO) measures can provide valuable information in evaluating patients’ health-related quality of life (HRQoL). Post hoc analysis of the AFTERCAB study was conducted to evaluate the HRQoL benefit of enzalutamide plus androgen deprivation therapy (ADT) compared to...

Descripción completa

Detalles Bibliográficos
Autores principales: Uemura, Hiroji, Kobayashi, Kazuki, Yokomizo, Akira, Hinotsu, Shiro, Horie, Shigeo, Kakehi, Yoshiyuki, Nonomura, Norio, Ogawa, Osamu, Oya, Mototsugu, Suzuki, Kazuhiro, Saito, Atsushi, Asakawa, Keiko, Uno, Satoshi, Naito, Seiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Nature Singapore 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510122/
https://www.ncbi.nlm.nih.gov/pubmed/35948732
http://dx.doi.org/10.1007/s10147-022-02221-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510122/
https://www.ncbi.nlm.nih.gov/pubmed/35948732
http://dx.doi.org/10.1007/s10147-022-02221-w

Ejemplares similares